BMC Cancer

official impact factor 3.15
Search for
Advanced search
BMC Cancer
Tools
Share this article
Open Access Pre-publication history

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer

Kristin L White, Robert A Vierkant, Catherine M Phelan, Brooke L Fridley, Stephanie Anderson, Keith L Knutson, Joellen M Schildkraut, Julie M Cunningham, Linda E Kelemen, V Shane Pankratz, David N Rider, Mark Liebow, Lynn C Hartmann, Thomas A Sellers and Ellen L Goode*

BMC Cancer 2009, 9:170 doi:10.1186/1471-2407-9-170

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 19 Dec 2008
Reviewer's Report Taimour Langaee 03 Mar 2009
Reviewer's Report Jingfang Gao 23 Mar 2009
Reviewer's Report Goutham Narla 29 Mar 2009
Resubmission - Version 2 Manuscript Author's comment 20 Apr 2009
Reviewer's Report Jingfang Gao 11 May 2009
Resubmission - Version 3 Manuscript Author's comment 22 May 2009
Editorial acceptance 28 May 2009
Published 06 Jun 2009